Back to list

Significance of observational data on type 2 diabetes management in North Africa

Aissa Boudiba *

Diabetes Research and Clinical Practice, pages S1 - S3

Published online Aug-2013


Article view:

Article Outline

References

  • 1 PN Papanikolaou, GD Christidi, JPA Ioannidis. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006;174(5):635-641 Crossref.
  • 2 DR Whiting, L Guariguata, C Weil, J Shaw. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-321 Crossref.
  • 3 International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium; 2011, updated 14 November 2012.
  • 4 International Diabetes Federation Middle East and North Africa region. http://www.idf.org/sites/default/files/attachments/IDF-MENA-Action-Plan-141009.pdf (18 April 2009)
  • 5 P Home, NE Naggar, M Khamseh, G Gonzalez-Galvez, C Shen, P Chakkarwar, et al. An observational non-interventional study of patients with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study. Diabetes Res Clin Pract. 2011;94:352-363 Abstract, Full-text, PDF, Crossref.
  • 6 SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577-1596 Crossref.
  • 7 K Niswender. Early and aggressive initiation of insulin therapy for type 2 diabetes: What is the evidence?. Clin Diab. 2009;27:60-68 Crossref.

Footnotes

Diabetology Department, Mustapha University Hospital, Algiers, Algeria Diabetology Department, Mustapha University Hospital, Algiers, Algeria

* Diabetology Department, Mustapha University Hospital, Algiers, Algeria

Back to list